European Union Drugs Agency - EUDA

European Union Drugs Agency - EUDA The European Union Drugs Agency (EUDA) is your source of drug-related expertise in Europe. We work alongside our partners to improve EU preparedness on drugs

We prepare and share independent, scientifically validated knowledge, alerts and recommendations.

05/06/2026

📊 What does the European Drug Report tell us?

It brings together data from across Europe to provide a clear, evidence-based picture of the drug situation.

Covering 29 countries, it supports policymakers, practitioners and researchers in understanding trends and shaping responses.

📅 The European Drug Report 2026 will be released in 25 languages on 9 June. Stay tuned for the latest insights.

🗣️ Have your say in shaping the EUDA Strategy 2030!Today, we open our public consultation, inviting stakeholders and cit...
05/06/2026

🗣️ Have your say in shaping the EUDA Strategy 2030!

Today, we open our public consultation, inviting stakeholders and citizens to share their views on the future of the European Union Drugs Agency.

🔵 What should we prioritise?
🟢 Where can we improve?
🟠 What will matter most in the years ahead?

Your input will directly contribute to our Strategy 2030 and help us strengthen our response to drug-related challenges across Europe.

👉 Share your perspective by 3 July: https://ec.europa.eu/eusurvey/runner/EUDAStartegy2030PublicConsultation?source=euda-sm

📢 EUDA webinar: Conceptualising drug market-related violenceHow is drug market-related violence defined and measured acr...
05/06/2026

📢 EUDA webinar: Conceptualising drug market-related violence

How is drug market-related violence defined and measured across Europe, and why does it matter for policy?

Join us as we explore:
🔵 Concepts and frameworks for understanding drug market-related violence
🟢 The spectrum of drug market-related violence, from homicides and shootings to robberies, victimisation and violence linked to intoxication
🟡 How and where violence occurs across the drug supply chain
🟣 How it is measured at local, national and European level

📅 Date and time: 16 June 2026 | 14:30–16:00 (WEST) | 15:30–17:00 (CEST)

Register now: https://www.euda.europa.eu/event/2026/06/euda-webinar-conceptualising-drug-market-related-violence_en

Drug market-related violence is reshaping communities across Europe.This month, we are focusing on how different aspects...
05/06/2026

Drug market-related violence is reshaping communities across Europe.

This month, we are focusing on how different aspects of the illicit drug market are interconnected. We will host a technical meeting in Lisbon and take part in events in Brussels, including and the conference of the European Forum for Urban Security (EFUS) on cities and drugs.

These moments bring together researchers, policymakers and city leaders to address some of the most complex challenges in drug policy.

We will share insights from all three events. Follow along to stay up to date with the evidence, the discussions and the most effective responses.

💉 What substances are being injected in Europe today?Our latest European Syringe Collection and Analysis Project Enterpr...
05/06/2026

💉 What substances are being injected in Europe today?

Our latest European Syringe Collection and Analysis Project Enterprise (ESCAPE) analysis looks directly at the contents of used syringes collected in harm reduction services across 23 cities, offering a timely picture of injecting practices.

📊 The findings highlight a diverse and evolving situation. Stimulants, such as co***ne and amphetamines, are often detected, while highly potent synthetic opioids continue to be detected in some settings. At the same time, he**in remains common in certain cities.

Half of the syringes analysed contained residues of two or more drug categories, pointing to frequent polysubstance use and increasing complexity in risk profiles.

These insights help inform more targeted prevention and harm reduction responses, grounded in laboratory-confirmed local data.

📘 Explore the full ESCAPE analysis:
https://www.euda.europa.eu/publications/data-factsheet/syringe-residues-analysis-data-escape-project_en

🔍 Learn more about the ESCAPE project:
https://www.euda.europa.eu/topics/escape_en

🔍 New drugs, new markets, new risks. Understanding what’s changing starts with solid facts.📘 On 9 June 2026, we will rel...
03/06/2026

🔍 New drugs, new markets, new risks. Understanding what’s changing starts with solid facts.

📘 On 9 June 2026, we will release the European Drug Report 2026 in 25 languages, presenting the latest evidence on drug use, supply, harms and responses across Europe, based on data from 29 countries.

This year’s report offers a comprehensive picture of Europe’s evolving drug landscape, with interactive visuals, open data and insights designed to support policy and practice.

👉 Find out more about the launch: euda.europa.eu/news/2026/coming-soon-european-drug-report-2026-be-released-9-june-brussels_en

Cooperation with our host country is central to how we work.Today, we welcomed the Portuguese Minister of Health, Dra An...
02/06/2026

Cooperation with our host country is central to how we work.

Today, we welcomed the Portuguese Minister of Health, Dra Ana Paula Martins, together with ICAD President Dra Joana Teixeira, to the EUDA in Lisbon for a courtesy visit and exchange on current drug-related challenges.

The meeting highlighted the close cooperation between the EUDA and the Portuguese authorities, with discussions touching on emerging issues across Europe, including new substances, responses in custodial settings and the role of new technologies in supporting preparedness and information exchange.

🤝 Ministério da Saúde
🤝 Instituto para os Comportamentos Aditivos e as Dependências

—

A cooperação com o nosso país anfitrião é fundamental para o nosso trabalho.

Recebemos hoje na EUDA, em Lisboa, a Ministra da Saúde, Dra Ana Paula Martins, juntamente com a Presidente do ICAD, Dra Joana Teixeira, para uma visita de cortesia e partilha de pontos de vista, sobre os atuais desafios relacionados com dr**as.

O encontro destacou a cooperação próxima entre a EUDA e as autoridades portuguesas, abordando questões emergentes na Europa, incluindo novas substâncias, respostas em contexto prisional e o papel das novas tecnologias no apoio à preparação e à partilha de informação.

🤝 Ministério da Saúde
🤝 Instituto para os Comportamentos Aditivos e as Dependências

How can EU agencies move from AI strategy to real-world solutions in their day-to-day work?Today, under our presidency o...
02/06/2026

How can EU agencies move from AI strategy to real-world solutions in their day-to-day work?

Today, under our presidency of the EU Justice and Home Affairs Agencies’ Network ( ), we are bringing together experts from across EU agencies to explore how artificial intelligence can support innovation, preparedness and digital transformation across sectors.

Discussions focus on practical tools and experiences already being developed within the EU institutional environment, from improving access to knowledge and information, to strengthening data governance, risk management and organisational change.

Participants will also explore initiatives such as our Nous AI project and exchange lessons learned on how to move from strategy to operational use, while ensuring responsible and transparent deployment.

🤝 By sharing concrete examples and building connections across disciplines, the meeting aims to support more effective collaboration and accelerate the adoption of AI solutions across the JHAAN community.

👉 Read more: euda.europa.eu/news/2026/eu-agencies-explore-practical-ai-solutions-field-justice-and-home-affairs_en

🧩 See upcoming events under our JHAAN presidency: euda.europa.eu/activities/jha_en

ℹ️ Ketamine in Europe: what are the latest trends and risks?In our recent webinar, we explored how ketamine is becoming ...
01/06/2026

ℹ️ Ketamine in Europe: what are the latest trends and risks?

In our recent webinar, we explored how ketamine is becoming more visible in parts of Europe’s drug market, and what this means for public health and monitoring efforts.

The discussion covered emerging patterns of use, developments in illicit markets and the health risks linked to non-medical use.

For healthcare professionals, the session also highlighted the importance of recognising ketamine-related health problems and ensuring appropriate care.

🎥 Watch the full recording here: https://www.euda.europa.eu/media-library/euda-webinar-ketamine-europe_en

🎉 The 200th issue of Drugnet Europe is out!📘 Since 1996, this newsletter has followed the evolution of Europe’s drug sit...
29/05/2026

🎉 The 200th issue of Drugnet Europe is out!

📘 Since 1996, this newsletter has followed the evolution of Europe’s drug situation and reported on key developments, publications and milestones in the life of the agency under four Directors.

The current issue features the latest updates, including:
🔹 European Drug Report 2026 launch (9 June)
🔹 New miniguide on dual disorders
🔹 Upcoming webinars and latest recordings
🔹 Research opportunities and vacancies

🔍 Read more here: https://mailchi.mp/euda/drugnet-europe-200-may2026

📩 Subscribe to Drugnet Europe: https://europa.us7.list-manage.com/subscribe?u=7661463396b2fc9d763392225&id=3f011a8795

Endereço

Praça Europa 1, Cais Do Sodré
Lisbon
1249-289

Horário de Funcionamento

Segunda-feira 09:00 - 17:30
Terça-feira 09:00 - 17:00
Quarta-feira 09:00 - 17:30
Quinta-feira 09:00 - 17:30
Sexta-feira 09:00 - 17:00

Telefone

+351211210200

Website

Notificações

Seja o primeiro a receber as novidades e deixe-nos enviar-lhe um email quando European Union Drugs Agency - EUDA publica notícias e promoções. O seu endereço de email não será utilizado para qualquer outro propósito, e pode cancelar a subscrição a qualquer momento.

Entre Em Contato Com A Organização

Envie uma mensagem para European Union Drugs Agency - EUDA:

Atalhos

Compartilhar